453
Views
7
CrossRef citations to date
0
Altmetric
Hemostasis and Thrombosis: Current Clinical Practice: Thrombosis and Malignancy

Thrombotic complications of polycythemia vera

, , , , &
Pages 319-323 | Published online: 18 Jul 2013

References

  • Tefferi A, Spivak JL. Polycythemia vera: scientific advances and current practice. Semin Hematol 2005; 42: 384–388.
  • Lesourd L, Pagniez P. Comptes Rendus Seances Soc Biol 1910; 68:746.
  • Brown GE, Giffin HZ. Peripheral arterial disease in polycythemiavera. Arch Intern Med 1930; 46: 705–717.
  • Rosenthal N, Bassen FA. Course of polycythemia. Arch Intern Med 1938; 62: 903–917.
  • Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton Set al. Cancer Genome Project: Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005; 365: 1054–1061.
  • James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, LacoutC et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polythaemia vera. Nature 2005; 434: 1144–1148.
  • Berlin NI. Diagnosis and classification of Polycythemia. Semin Hematol 1975; 12: 339–351.
  • Singh V, Sinha SK, Nain CK, Bambery P, Kaur U, Verma S et al.Budd-Chiari syndrome: our experience of 71 patients. J Gastroenterol Hepatol 2000; 15: 550–554.
  • Ania BJ, Suman VJ, Sobell JL, Codd MB, Siluerstein MN, MeltonU. Trends in the incidence of polycythemia vera Among Olmsted Country, Minnesota Residents. 1935-1989. Am J Hematol 1994; 47: 89–93.
  • Berglund S, Zettervall O. Incidence of polycythemia vera in a defined population. Eur J Hematol 1992; 48: 20–26.
  • Modan B. An epidemiological study of polycythemia vera. Blood 1965; 26: 657–667.
  • Gruppo Italiano studio Policitemia. Polycythemia vera: the natural history of 1213 patients followed for 20 years. Ann Intern Med 1995; 123: 656–664.
  • Calabresi P, Meyer OO. Polycythemia vera. Ann Intern Med 1959; 50: 1182–1216.
  • Streiff MB, Smith B, Spiwak JL. Diagnosis and management of polycythemia vera in the era since the polycythemia study group: a survey of American Society of Hematology members practice patterns. Blood 2002; 29:1144-1149.
  • Elliot MA, Teffari A. Thrombosis and hemorrhage in Polycythemia vera and essential thrombocythemia. Br J Hematol 2005; 128: 275–290.
  • Cardin F, Graffeo M, Mc Cormick PA, McIntyre N, Burroughs A. Adult 'idiopathic' extrahepatic venous thrombosis. Im-portance of putative latent myeloproliferative disorders and comparisons with cases with known etiology. Dig Dis Sci 1992; 37: 335–339.
  • Kessler CM. Propensity of heamorrhage and thrombosis in chronic Myeloproliferative disorders. Semin Hematol 2004; 41: 10–14.
  • Pearson TC. Haemalological considerations in the pathogenesis of vascular occlusive events in polycythemia vera. Sem Thromb Hemost 1997; 23: 433–439.
  • Berk PD, Goldberg JD, Donovan PB, Fruchtman SM, Berlin NI, Wasserman LR. Therapeutic recommendations in polycythemia vera based on polycythemia vera study group protocols. Semin Hematol 1986; 23: 132–143.
  • Longley S, Caldwell JR, Panush RS. Paraneoplastic vasculitis. Unique syndrome of cutaneous angiitis and arthritis associated with myeloproliferative disorders. Am J Med 1986; 80: 127–130.
  • Passamonti F, Rumi E, Pungolino E, Mlabarba L, Bertazzoni P, Valentini M et al. Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombo-cythemia. Am J Med 2004; 117: 755–761.
  • Finnazi G, CarusoV, Marchioli R, Capnist G, Chisesi T, Finelli C et al. Acute leukemia in polycythemia vera. An analysis of 1638 Patients enrolled in a prospective observational study. Blood 2004; 105: 2664–2670.
  • Finnazi G. A prospective analysis of thrombotic events in the European collaboration study on low dose aspirin in polycythemia (ECLAP). Pathol Biol (Paris) 2004; 52: 285–288.
  • Wasserman LR. Polycythemia vera - its course and treatment relation to myeloid metaplasia and leukemia. Bull N Y Acad Med 1954; 30: 343–375.
  • Najean Y, Deschamps A, Dresch C, Daniel MT, Rain JD, Arrango JP. Acute leukemia and myelodysplasia in polycythemia vera: a clinical study with long-term follow-up. Cancer 1988; 61: 89–95.
  • Neu LT, Shuman MA, Brown EB. Polycythemia vera and acute leukemia. Ann Intern Med 1975; 83: 672–673.
  • Tefferi A. Hydroxyurea vindicated: lack of leukemogenicity in Polycythemia vera. Curr Hematol Rep 2005; 4: 211–212.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.